Is there a predictive significance of ABO blood group on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer?

被引：5
作者：
Tanriverdi, Ozgur [1 ]
机构：
[1] Mugla Sitki Kocman Univ, Dept Med Oncol, Onkoloji Bolumu, Fac Med,Mugla Univ Egitim & Arastirma Hastanesi, TR-48000 Mugla, Turkey
来源：
MEDICAL ONCOLOGY | 2015年 / 32卷 / 01期
关键词：
Blood group; Thrombocytopenia; Colon cancer; COLORECTAL-CANCER; OVARIAN-CANCER; BREAST-CANCER; ANTIGENS; EXPRESSION; RISK; PROGRESSION; MANAGEMENT; PLATELETS; PROGNOSIS;
D O I：
10.1007/s12032-014-0384-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemotherapy-induced thrombocytopenia (CIT) is the most important cause of thrombocytopenia in cancer patients. In this paper, I discussed the effect of ABO blood group on CIT in patients with stage III colon cancer. In a pilot study, a total of 131 (72 men, 55 %) eligible patients with stage III colon cancer were divided into two groups according to whether they had CIT. Both groups were compared using demographic, histopathological, and laboratory variables. CIT was detected in 51 (40 %) of 131 patients. The incidence of CIT had a significant increased in patients with 0 blood group compared to other blood groups. It was concluded that the relationship between blood group 0 and the presence of CIT in patients with stage III colon cancer is independent of other study variables (P = 0.035, OR 3.14, 95 % CI 1.16-7.01). In conclusion, I hypothesized that 0 blood group may predict to differentiate high-risk patients for CIT.
引用
收藏
页数：4
相关论文
共 22 条
  • [1] A Rational Approach to the Diagnosis and Management of Thrombocytopenia in the Hospitalized Patient
    Arnold, Donald M.
    Lim, Wendy
    [J]. SEMINARS IN HEMATOLOGY, 2011, 48 (04) : 251 - 258
  • [2] Prevention of Chemotherapy-Induced Anemia and Thrombocytopenia by Constant Administration of Stem Cell Factor
    Bartucci, Monica
    Dattilo, Rosanna
    Martinetti, Daniela
    Todaro, Matilde
    Zapparelli, Giuseppina
    Di Virgilio, Antonio
    Biffoni, Mauro
    De Maria, Ruggero
    Zeuner, Ann
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (19) : 6185 - 6191
  • [3] Barrett's, blood groups and progression to oesophageal cancer: is nitric oxide the link?
    Caygill, Christine P. J.
    Royston, Christine
    Charlett, Andre
    Wall, Christine M.
    Gatenby, Piers A. C.
    Ramus, James R.
    Watson, Anthony
    Winslet, Marc
    Hourigan, Christopher S.
    Bardhan, Karna Dev
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2011, 23 (09) : 801 - 806
  • [4] Blood group A and B antigens are strongly expressed on platelets of some individuals
    Curtis, BR
    Edwards, JT
    Hessner, MJ
    Klein, JP
    Aster, RH
    [J]. BLOOD, 2000, 96 (04) : 1574 - 1581
  • [5] ABO BLOOD-GROUPS, RHESUS TYPES, AND COLORECTAL ADENOCARCINOMA - A RETROSPECTIVE STUDY OF 747 CASES
    HALVORSEN, TB
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 (08) : 979 - 983
  • [6] OVARIAN-CANCER AND ABO BLOOD-GROUPS
    HENDERSON, J
    SEAGROATT, V
    GOLDACRE, M
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1993, 47 (04) : 287 - 289
  • [7] Hitron Anna, 2011, J Oncol Pharm Pract, V17, P312, DOI 10.1177/1078155210380293
  • [8] Jelic S, 2006, AM J CANC, V6, P372
  • [9] ABO Blood Group and Risk of Colorectal Cancer
    Khalili, Hamed
    Wolpin, Brian M.
    Huang, Edward S.
    Giovannucci, Edward L.
    Kraft, Peter
    Fuchs, Charles S.
    Chan, Andrew T.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 1017 - 1020
  • [10] Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
    Levin, Robert D.
    Daehler, MaryAnn
    Grutsch, James F.
    Hall, John L.
    Gupta, Digant
    Lis, Christopher G.
    [J]. BMC CANCER, 2010, 10
123